Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13147 | 793 | 42.7 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2292 | 4139 | MELANOCORTIN//MELANOCORTIN RECEPTOR//MELANOCORTIN RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ALPHA MELANOCYTE STIMULATING HORMONE | Author keyword | 19 | 22% | 9% | 74 |
2 | MELANOCORTIN PEPTIDES | Author keyword | 14 | 60% | 2% | 15 |
3 | ALPHA MSH | Author keyword | 13 | 18% | 9% | 69 |
4 | LUDWIG BOLTZMANN CELL BIOL IMMUNOBIOL SKIN | Address | 9 | 30% | 3% | 24 |
5 | MELANOCORTINS | Author keyword | 7 | 19% | 4% | 35 |
6 | SECT PHARMACOL MOL MED | Address | 7 | 67% | 1% | 6 |
7 | ACTH 1 24 | Author keyword | 5 | 60% | 1% | 6 |
8 | PHARMACEUT CHEM TOXICOL | Address | 5 | 34% | 2% | 12 |
9 | KPV | Author keyword | 4 | 75% | 0% | 3 |
10 | PRECLIN INVEST | Address | 4 | 27% | 2% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALPHA MELANOCYTE STIMULATING HORMONE | 19 | 22% | 9% | 74 | Search ALPHA+MELANOCYTE+STIMULATING+HORMONE | Search ALPHA+MELANOCYTE+STIMULATING+HORMONE |
2 | MELANOCORTIN PEPTIDES | 14 | 60% | 2% | 15 | Search MELANOCORTIN+PEPTIDES | Search MELANOCORTIN+PEPTIDES |
3 | ALPHA MSH | 13 | 18% | 9% | 69 | Search ALPHA+MSH | Search ALPHA+MSH |
4 | MELANOCORTINS | 7 | 19% | 4% | 35 | Search MELANOCORTINS | Search MELANOCORTINS |
5 | ACTH 1 24 | 5 | 60% | 1% | 6 | Search ACTH+1+24 | Search ACTH+1+24 |
6 | KPV | 4 | 75% | 0% | 3 | Search KPV | Search KPV |
7 | MELANOCORTIN RECEPTORS | 3 | 15% | 3% | 21 | Search MELANOCORTIN+RECEPTORS | Search MELANOCORTIN+RECEPTORS |
8 | DOPA POSITIVE MELANOCYTE | 3 | 100% | 0% | 3 | Search DOPA+POSITIVE+MELANOCYTE | Search DOPA+POSITIVE+MELANOCYTE |
9 | MELANOCORTIN MC4 RECEPTORS | 3 | 100% | 0% | 3 | Search MELANOCORTIN+MC4+RECEPTORS | Search MELANOCORTIN+MC4+RECEPTORS |
10 | ALPHA MELANOCYTE STIMULATING HORMONE ALPHA MSH | 3 | 24% | 1% | 10 | Search ALPHA+MELANOCYTE+STIMULATING+HORMONE+ALPHA+MSH | Search ALPHA+MELANOCYTE+STIMULATING+HORMONE+ALPHA+MSH |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL BRAIN INFLAMMATION | 39 | 80% | 3% | 24 |
2 | MSH | 34 | 31% | 12% | 92 |
3 | MELANOCYTE STIMULATING HORMONE | 34 | 13% | 32% | 254 |
4 | NEUROPEPTIDE ALPHA MSH | 24 | 68% | 3% | 21 |
5 | ACTH 1 24 | 23 | 70% | 2% | 19 |
6 | INTERLEUKIN 1 INDUCIBLE RESPONSES INVIVO | 23 | 100% | 1% | 10 |
7 | TARGET CELL SELECTIVITY | 21 | 90% | 1% | 9 |
8 | EXPERIMENTAL HEART TRANSPLANTATION | 20 | 100% | 1% | 9 |
9 | PEPTIDES INHIBIT PRODUCTION | 17 | 72% | 2% | 13 |
10 | PROHORMONE CONVERTASES 1 | 17 | 100% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
alpha-melanocyte-stimulating hormone and related tripeptides: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases | 2008 | 104 | 176 | 65% |
Targeting melanocortin receptors as a novel strategy to control inflammation | 2004 | 225 | 324 | 42% |
Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH | 1997 | 262 | 29 | 66% |
Targeting melanocortin receptors as potential novel therapeutics | 2006 | 89 | 143 | 44% |
The melanocortin system in leukocyte biology | 2007 | 40 | 128 | 67% |
Melanocortins as potential therapeutic agents in severe hypoxic conditions | 2012 | 9 | 188 | 44% |
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress | 2000 | 357 | 381 | 22% |
alpha-Melanocyte stimulating hormone, inflammation and human melanoma | 2006 | 53 | 86 | 41% |
Quantitative analysis of MC1R gene expression in human skin cell cultures | 2006 | 43 | 102 | 42% |
Neuroprotective actions of melanocortins: a therapeutic opportunity | 2008 | 51 | 87 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUDWIG BOLTZMANN CELL BIOL IMMUNOBIOL SKIN | 9 | 30% | 3.0% | 24 |
2 | SECT PHARMACOL MOL MED | 7 | 67% | 0.8% | 6 |
3 | PHARMACEUT CHEM TOXICOL | 5 | 34% | 1.5% | 12 |
4 | PRECLIN INVEST | 4 | 27% | 1.5% | 12 |
5 | ONCOL EXPT SURG | 3 | 32% | 1.1% | 9 |
6 | LUDWIG BOLTZMAN CELLBIOL IMMUNOBIOL SKIN | 3 | 100% | 0.4% | 3 |
7 | SPERIMENTAZ PRECLIN | 3 | 100% | 0.4% | 3 |
8 | LOCE BORDET | 2 | 67% | 0.3% | 2 |
9 | SECT HUMAN MORPHOL | 2 | 27% | 0.9% | 7 |
10 | NEUROENDOCRINOL SKIN INTERDISCIPLINARY ENDO | 2 | 40% | 0.5% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000259054 | MELANOCORTIN//MELANOCORTIN 4 RECEPTOR//MELANOCORTIN RECEPTOR |
2 | 0.0000134776 | SEMAX//ORG 2766//ACTH4 9 ANALOG |
3 | 0.0000109866 | MELANOGENESIS//MITF//TYROSINASE |
4 | 0.0000107419 | CDKN2A//MC1R//MELANOCORTIN 1 RECEPTOR |
5 | 0.0000093321 | PROOPIOMELANOCORTIN//PROOPIOCORTIN//PROOPIOMELANOTROPIN |
6 | 0.0000090664 | MELANOMA IMAGING//IMAGERIE MOL THER IE VECTORISEE//MELANOMA TARGETING |
7 | 0.0000082171 | HAIR CORTISOL//CIHR GSK CHAIR PEDIAT CLIN PHARMACOL//OBES CGG |
8 | 0.0000063860 | MEDTAYSIDE CHILD HLTH//CHEMIOXYEXCITATION//GLUTATHIONE DISEQUILIBRIUM |
9 | 0.0000049317 | 2 SEC BUTYLPHENYL METHYLCARBAMATE BPMC//CENTRAL CHOLINERGIC SYSTEMS//CHOLINERGIC HYPERTENSION |
10 | 0.0000048551 | RABBIT CONSCIOUS//CENTRAL HYPERTENSIVE AGENT//THORACIC ELECTRICAL IMPEDANCE |